跳至主要内容
临床试验/TCTR20210506003
TCTR20210506003已完成不适用

eutrophil to Lymphocyte Ratio as A Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy in HRH Princess Maha Chakri Sirindhorn Medical Center:retrospective crossectional study

HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University0 个研究点目标入组 16 人开始时间: 2021年5月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16

研究概览

简要总结

The neutrophil lymphocyte ratio could be one of the marker that increase in NAION patients. The advantages of the neutrophil lymphocyte ratio were the low cost and the high availability of the resource. Moreover it could be used as the predictive factor for the visual outcomes of the NAION patients.

研究设计

研究类型
Observational

入排标准

年龄范围
N/A (No limit) 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Acute painless visual loss
  • 2. Presence of relative afferent pupillary defect
  • 3. Visual field defect which is compatible with disease
  • 4. Optic nerve head change that is consistent with disease
  • 5. No other abnormal ophthalmic findings that can mimic other ophthalmic disease

排除标准

  • 1. Subjects with underlying disease effected a blood test result e.g. inflammatory diseases, leukemia, thrombocytosis, and Multiple myeloma
  • 2. History of smoking and alcohol drinking
  • 3. Retinal diseases e.g. diabetic retinopathy, retinal vein occlusion and hypertensive retinopathy
  • 4. Glaucoma diseases
  • 5. Other Neuro-opthalmic diseases 6.the patient who received any kind of treatment for NAIO

研究者

发起方
HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University

相似试验